Format

Send to:

Choose Destination
See comment in PubMed Commons below
Chron Respir Dis. 2009;6(1):19-29. doi: 10.1177/1479972308095936.

Exhaled nitric oxide in the diagnosis and management of asthma: clinical implications.

Author information

  • 1Center for Sleep and Respiratory Neurobiology, University of Pennsylvania School of Nursing, Philadelphia, Pennsylvania 19104, USA. gwrodway@hotmail.com

Abstract

Exhaled nitric oxide (eNO) used as an aid to the diagnosis and management of lung disease is receiving attention from pulmonary researchers and clinicians alike because it offers a noninvasive means to directly monitor airway inflammation. Research evidence suggests that eNO levels significantly increase in individuals with asthma before diagnosis, decrease with inhaled corticosteroid administration, and correlate with the number of eosinophils in induced sputum. These observations have been used to support an association between eNO levels and airway inflammation. This review presents an update on current opportunities regarding use of eNO in patient care, and more specifically on its potential usage for asthma diagnosis and monitoring. The review will also discuss factors that may complicate use of eNO as a diagnostic tool, including changes in disease severity, symptom response, and technical measurement issues. Regardless of the rapid, convenient, and noninvasive nature of this test, additional well-designed, long-term longitudinal studies are necessary to fully evaluate the clinical utility of eNO in asthma management.

PMID:
19176709
[PubMed - indexed for MEDLINE]
PMCID:
PMC2724767
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for HighWire Icon for PubMed Central
    Loading ...
    Write to the Help Desk